期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

2型糖尿病肾病与PPAR-γ2 Pro12Ala单核苷酸多态性的相关性研究 被引量：3

The relationship between the pro12Ala polymorphism in PPAR-γ2 gene and diabetic nephropathy in Baotou
下载PDF
导出
摘要 PPAR-γ2Pro12Ala(P12A)单核苷酸多态性(SNP),包括PP、PA、AA三种基因型,由于AA突变率很低,用XA作为PA、AA共同代称。受试者301例,用RFLP-PCR行基因型测定。单纯T2DM组XA基因型频率明显低于正常对照组(0.101vs0.283,P<0.05);糖尿病肾病(DN)组及肌酐清除率减低(DN2)组中XA基因型者UAlb/Cr有明显降低(P<0.05)。XA基因型携带者T2DM发病率降低,与DN发病无关。 301 subjects were selected. The pro12Ala polymorphism of PPAR-γ2 gene was screened by polymerase chain reaction and restriction fragment length polymorphism （PCR-RFLP） in 301 subjects. The frequency of the Pro12Ala mutation was significantly lower in T2DM than in control group（0. 101 vs 0. 283,P〈 0.05）. The genotype of XA may be independent proctective factor for the pathogenesis of T2DM, but showed no relationship with DN （OR=0. 284,95% CI=0. 132-0. 611）.
作者 魏枫 王津京 王彩丽 霍晓静 薛晔霞 白琳院
机构地区 内蒙古科技大学包头医学院第一附属医院内分泌科 内蒙古科技大学包头医学院第一附属医院肾内科
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2008年第11期679-680,共2页 Chinese Journal of Diabetes
基金 包头医药卫生基金(2005G30020-21)
关键词 多态性 单核苷酸 过氧化物酶体增殖物受体γ2 基因型 糖尿病肾病 Polyrnorphism, Mononucleotide Peroxisome proliferator-activated receptor γ2 Genotype Diabetic nephropathy
分类号 R587.2 [医药卫生—内分泌]
  • 相关文献

参考文献5

二级参考文献11

  • 1Kubota N, Terauchi Y, Miki H, et al.PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell, 1999,4:597-609.
  • 2Mori H, Ikegami H,Kawaguchi Y, et al. The Pro12→Ala Substitution in PPARγ Is Associated With Resistance to Development of Diabetes in the General Population. Diabetes, 2001, 50:891-894.
  • 3Yamauchi T, Kamon J, Waki H, et al. The mechanisms by which both heterozygous PPARγ deficiency and PPARγ agonist improve insulin resistance. J Biol Chem, 2001,276: 41245-41254.
  • 4Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes.Nature,2001,409:307-312.
  • 5Yen CJ, Beamer BA, Negri C, et al. Molecular scanning of the human peroxisome proliferator activiated receptor gamma(hPPARγ)gene in diabetic Caucasians: identification of a Pro12 Ala PPARγ2 missense mutation. Biochem Biophys Res Commun,1997,241:270-274.
  • 6Deeb SS,Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet,1998, 20:284-287.
  • 7Valve R,Sivenius K,Miettinen R, et al. Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women. J Clin Endocrinol Metab,1999,84:3708-3712.
  • 8EK J, Urhammer SA, Sorensen TIA, et al. Homozygosity of the Pro12Ala variant of the peroxisome proliferator-activated receptor-γ2(PPARγ2):divergent modulating effects on body mass index in obese and lean Caucasian men.Diabetologia, 1999,42:892-895.
  • 9Beamer BA,Yen CJ, Andersen RE, et al. Association of the Pro12Ala variant in the peroxisome proliferator-activiated receptor-γ2 gene with obesity in two Caucasian populations.Diabetes, 1998,47:1806-1808.
  • 10钱荣立.关于糖尿病的新诊断标准与分型[J].中国糖尿病杂志,2000,8(1):5-6. 被引量：2313

共引文献32

同被引文献38

  • 1刘峰,陈楠.过氧化物酶体增殖物激活受体与肾脏病研究新进展[J].中国中西医结合肾病杂志,2005,6(1):51-54. 被引量：3
  • 2Issemann I,Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators[J].{H}NATURE,1990,(6294):645-650.
  • 3陆再英.内科学[M]人民卫生出版社,2008776.
  • 4Uruno A,Matsuda K. Effects of pparγ agonists against vascular and renal dysfunction[J].Curr Mol Pharmacol,2012,(02):248-254.
  • 5Argmann CA,Cock TA,Auwerx J. Peroxisome proliferator @ activated receptor:the more the merrier[J].{H}European Journal of Clinical Investigation,2005,(02):82-92.
  • 6Desvergne B,Michalik L,Wahli W. Be fit or be sick:peroxisome proliferator · activated receptors are down the road[J].Mol Endocfi nol,2004,(06):1321-1332.
  • 7Florez JC,Jablonski KA,Sun MW. Effects of the type 2 diabetes @ assoc iated pparg P12A polymorphism on progression to diabetes and response to troglitazone[J].{H}Journal of Clinical Endocrinology and Metabolism,2007,(04):1502-1509.
  • 8Herrmann J,ringel JG,wang JA,staessen E. brand,Berlin diabetes mellitus (bediam) study peroxisome proliferatoractivated receptor-gamma 2 polymorphism pro12ala is associated with nephropathy in type 2 diabetes.The Berlin Diabetes Mellitus Study[J].{H}DIABETES,2002,(08):2653-2657.
  • 9Caramori ML,Canani LH,Costa LA. The human peroxisome proliferator @ activated receptor72 (ppar72) prol 2 ala polymor @ phism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes[J].{H}DIABETES,2003,(12):3010-3013.
  • 10Pollex RL,Mamakeesick M,Zinman B. Peroxisome proliferator-activated receptor polymorphism prol 2 ala is associated with nephropathy in type 2 diabetes[J].Diabetes Complications,2007,(03):166-171.

引证文献3

二级引证文献8

中国糖尿病杂志
2008年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部